Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

VARN SUPERSPEED AC

NFPA

PRODUCT USE

Fountain additive for lithographic printing.

SYNONYMS

"fountain additive", "lithographic printing", LO12033

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Considered an unlikely route of entry in commercial/industrial environments.  Ingestion may result in nausea, abdominal irritation, pain and vomiting.  

EYE

  Although the liquid is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  Not normally a hazard due to non-volatile nature of product.  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  

CHRONIC HEALTH EFFECTS

  Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems.  Glyceryl triesters (triglycerides), following ingestion, are metabolised to monoglycerides, free fatty acids and glycerol, all of which are absorbed in the intestinal mucosa and undergo further metabolism. Little or no acute, subchronic or chronic oral toxicity was seen in animal studies unless levels approached a significant percentage of calorific intake. Subcutaneous injections of tricaprylin in rats over a five-week period caused granulomatous reaction characterised by oil deposits surrounded by macrophages. Diets containing substantial levels of tributyrin produced gastric lesions in rats fed for 3-35 weeks; the irritative effect of the substance was thought to be the cause of tissue damage.  Dermal application was not associated with significant irritation in rabbit skin; ocular exposures were, at most, mildly irritating to rabbit eyes. No evidence of sensitisation or photosensitisation was seen in a guinea pig maximisation test. Most of the genotoxicity test systems were negative. Tricaprylin, trioctanoin and triolein have been used, historically, as vehicles in carcinogenicity testing of other chemicals. In one study, subcutaneous injection of tricaprylin, in newborn mice, produced more tumours in lymphoid tissue than were seen in untreated animals whereas, in another study, subcutaneous or intraperitoneal injection in 4- to 6-week old female mice produced no tumours. Trioctanoin injected subcutaneously in hamster produced no tumours; when injected intraperitoneally in pregnant rats there was an increase in mammary tumours among the off-spring but similar studies in pregnant hamsters and rabbits showed no tumours in the off-spring.  The National Toxicological Program conducted a 2-year study in rats given tricaprylin by gavage. The treatment was associated with a statistically significant dose-related increase in pancreatic acinar cell hyperplasia and adenoma but there were no acinar carcinomas.  Tricaprylin is not teratogenic to mice or rats but some reproductive effects were seen in rabbits. A low level of foetal eye abnormalities and a small percentage of abnormal sperm were reported in mice injected with trioctanoin.  Some glycol esters and their ethers cause wasting of the testicles, reproductive changes, infertility and changes to kidney function. Shorter chain compounds are more dangerous. Higher concentrations and prolonged exposure can cause blood in the urine.  As with any chemical product, contact with unprotected bare skin; inhalation of vapor, mist or dust in work place atmosphere; or ingestion in any form, should be avoided by observing good occupational work practice.